Sr Manager, Medical Affairs Operations at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

BSc, MSc in life science related field or comparable work experience
Minimum 5+ years of relevant experience in the pharmaceutical or health care industry, ideally in Medical Affairs
Strong project management skills
Experience with digital processes and solutions (expertise in Material Review platforms such as Veeva MedInquiry, VeevaVault, MedDocs, etc.)
Superior organisation and prioritisation skills
Ability to work in a site-based role in Foster City, CA (preferred) or Raleigh, NC (no remote work)

Responsibilities

Drive delivery of technologies and platforms to meet Medical Affairs customer relationship and performance measurement needs
Partner with Medical Affairs Excellence, Medical Affairs Affiliate leaders, Global Medical Strategy and Operations Leaders, and the IT organization to implement technology solutions
Advise internal stakeholders on enabling business capabilities with enterprise technology tools
Align tools to performance expectations and continuously adapt compliant, efficient, and effective technologies to changing business needs
Work within a matrix environment to cultivate tool advocacy with senior leadership
Plan and implement the Canada Medical Grants Program and participate in the Grant Review Committee
Lead the medical planning process at the TA level, measurement of Medical Affairs effectiveness, departmental goal setting and tracking; create reports and presentations
Provide budget oversight in collaboration with the Country Medical Director and local Finance Lead
Provide project management to the MLT
Oversee and lead initiatives to raise standards within Medical Affairs, including training programs; partner with HR and L&D for training and development plans
Ensure consistency and efficiency of departmental operations and alignment with company procedures, policies, and processes
Provide quality oversight of Medical Affairs activities including SOPs, training, audit programs, and related recordings
Develop, refine, and maintain Standard Operating Procedures for Medical Affairs activities
Work on special projects in close collaboration with the Country Medical Director

Skills

Medical Affairs

Technology Platforms

Performance Measurement

Stakeholder Management

IT Implementation

Matrix Environment

Compliance

Enterprise Tools

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free